EEEmine Ünal Evren

Emine Ünal Evren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emine Ünal Evren has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Medical Students’ Tobacco Consumption Status and Experiences with Smoke-free Law Violations in Enclosed Spaces in Türkiye and Northern Cyprus

    by Dilek Aslan, Pınar Ay, Kervin Raymond, Özen Aşut, Gulifeiya Abuduxike, Meltem Şengelen, Duygu Çekici, Füsun Yıldız, Emine Ünal Evren, Ali Fuat Kalyoncu, et al.

    Medical Students’ Tobacco Consumption Status and Experiences with Smoke-free Law Violations in Enclosed Spaces in Türkiye and Northern Cyprus - Thoracic Research and Practice


  • Open Access

    Antibiotic resistance in community-acquired urinary tract infections. Did the COVID-19 pandemic cause a change?

    by Emine Unal Evren, Hakan Evren, Nilufer Galip

    Introduction: This study aimed to evaluate the antimicrobial resistance rates before and during the coronavirus disease 2019 (COVID-19) pandemic. Methodology: 897 positive urine cultures collected from outpatients of all ages between January 1, 2017, and December 31, 2022, were analyzed. The antibiotic susceptibility tests (AST) were analyzed by using an automated VITEK 2 (Biomerieux, Marcy-l`Étoile, France) compact system. AST results were interpreted according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria. The significance of resistance rates was tested with the Pearson’s Chi-squared test and risk factors of extended-spectrum beta-lactamases (ESBL) positiveness were identified with binary logistic regression. Results: E. coli (n = 774) and K. pneumoniae (n = 123) were isolated in 86.3% and 13.7% of the patients, respectively. During this period of six years before and during pandemic, the highest resistance rate was found for cefuroxime axetil (49.8%) and the lowest for nitrofuratoin (6.0%). Statistically significant increases in resistance compared to the pre-pandemic period were only determined for cefixime (37.2 vs 46.0%) and ceftriaxone (37.6 vs 46.1%) (p = 0.010). ESBL positivity was the most important factor that statistically increased resistance for all antibiotics (p < 0.001 for all). Being male [OR (95% CI) 1.56 (1.13-2.15)] and presenting to the clinic after the pandemic period [1.4 (1.1-1.8)] were found to increase ESBL positiveness significantly. Conclusions: Ceftriaxone and Cefixime resistance rates and ESBL positivity among the uropathogens E. coli and K. pneumoniae increased during the pandemic compared with the pre-pandemic period. ESBL positivity was higher in males.

  • Open Access

    Long-COVID-19 in Asymptomatic, Non-Hospitalized, and Hospitalized Populations: A Cross-Sectional Study

    by Aysegul Bostanci, Umut Gazi, Ozgur Tosun, Kaya Suer, Emine Unal Evren, Hakan Evren, Tamer Sanlidag

    A substantial proportion of coronavirus disease 2019 (COVID-19) survivors continue to suffer from long-COVID-19 (LC) symptoms. Our study aimed to determine the risk factors for LC by using a patient population from Northern Cyprus. Subjects who were diagnosed with severe acute respiratory syndrome-2 (SARS-CoV-2) infection in our university hospital were invited and asked to fill in an online questionnaire. Data from 296 survivors who had recovered from COVID-19 infection at least 28 days prior the study was used in the statistical analysis. For determination of risk factors for “ongoing symptomatic COVID-19 (OSC)” and “Post-COVID-19 (PSC)” syndromes, the patient population was further divided into group 1 (Gr1) and group 2 (Gr2), that included survivors who were diagnosed with COVID-19 within 4-12 weeks and at least three months prior the study, respectively. The number of people with post-vaccination SARS-CoV-2 infection was 266 (89.9%). B.1.617.2 (Delta) (41.9%) was the most common SARS-CoV-2 variant responsible for the infections, followed by BA.1 (Omicron) (34.8%), B.1.1.7 (Alpha) (15.5%), and wild-type SARS-CoV-2 (7.8%). One-hundred-and-nineteen volunteers (40.2%) stated an increased frequency of COVID-19-related symptoms and experienced the symptoms in the week prior to the study. Of those, 81 (38.8%) and 38 (43.7%) were from Gr1 and Gr2 groups, respectively. Female gender, chronic illness, and symptomatic status at PCR testing were identified as risk factors for developing OSC syndrome, while only the latter showed a similar association with PSC symptoms. Our results also suggested that ongoing and persistent COVID-19-related symptoms are not influenced by the initial viral cycle threshold (Ct) values of the SARS-CoV-2, SARS-CoV-2 variant as well as vaccination status and type prior to COVID-19. Therefore, strategies other than vaccination are needed to combat the long-term effect of COVID-19, especially after symptomatic SARS-CoV-2 infection, and their possible economic burden on healthcare settings.


  • Open Access

    Comparison of Adverse Effects of COVID-19 Vaccines Among Elderly: Pfizer/BioNTech Versus CoronaVac

    by Hakan Evren, Emine Ünal Evren, Serap Argun Bariş, Figen Gülen İnCe, Cenk Soydan, Ömür Çınar Elçi̇, Füsun Yildiz

    PURPOSE: The SARS-CoV-2 infection has triggered the Covid-19 pandemic with enormous public health and economic consequences. The safety and efficacy of currently available Covid-19 vaccines have been demonstrated in few studies; however, further information on specific high-risk groups like the elderly with co-morbidities is needed. In this cross-sectional study, we aimed to compare the adverse side effects of two different Covid-19 vaccines (RNA-based Pfizer/BioNTech and inactivated CoronaVac) among the elderly with co-morbidities. MATERIAL AND METHODS: We selected a total of 800 participants 65 years or older who received either one of the vaccines. We collected data on the possible side effects that have been previously attributed to coronavirus vaccination via quantitative telephone interviews. RESULTS: We found that both CoronaVac and Pfizer/BioNTech were safe in adults over 65 years old, even with co-morbidities. The most common side effects were pain on the injection site and fatigue. Adverse effects, particularly allergic reactions, were higher in Pfizer/BioNTech vaccinated group compared to the CoronaVac group. CONCLUSION: In conclusion, even with co-morbidities, both vaccines were well-tolerated among the elderly. As this specific group was largely excluded from the previous trials, we believe that this study may have a contributing impact on vaccine acceptance and health policy decision-making.


  • Kan ve Vücut Sıvıları ile Bulaşan Enfeksiyonlar Açısından Hasta Güvenliği

    by Emine Ünal Evren, Ayşın ZEYTİNOĞLU, Hakan Evren

    Enfekte kan ve vücut sıvıları ile bulaşan hastalık etkenlerinden hepatit B, hepatit C ve insan immun yetmezlik (HIV) virüsleri sağlık kurumlarında hem sağlık çalışanı hem de hasta biyogüvenliğini tehdit eden enfeksiyonlara neden olmaktadır. Sağlık merkezlerinde kesici delici alet yaralanmaları sonucunda kan ve vücut sıvılarına direkt temasla bulaşabilen patojenler arasında bu üç virüs, oluşturdukları enfeksiyonların ciddiyeti, halk sağlığını tehdit etmeleri ve bulaş gerçekleştiğinde ortaya çıkabilecek etik ve hukuki boyut nedeniyle de ön plana çıkmaktadır. Tıbbi girişimler sırasında perkutan yaralanmalar sonrasında gerek hastadan sağlık çalışanına gerekse çalışandan hastaya bu virüslerin bulaşma riskleri; patojenin tipi, kaynak vakanın viral yükü, yaralanmanın şekli ve bulaşan kan volümü gibi faktörlerden etkilenmektedir. Sağlık çalışanları arasındaki hepatit B virüs enfeksiyonlarının %37’ sinin, hepatit C virüs enfeksiyonlarının %39’unun, HIV enfeksiyonlarının ise yaklaşık %5’inin peruktan yaralanmalar sonucunda geliştiği bildirilmektedir. Öte yandan sağlık çalışanından uyguladığı invaziv girişimler sırasında bu enfeksiyonların hastalara da bulaşıyor olması tüm dünyada daha az irdelenmiş bir konudur. Amerika Birleşik Devletleri, Kanada, İngiltere ve Avustralya enfekte sağlık çalışanından hastaya olası bulaşmaların önlenmesine yönelik önlemleri ve denetimle ilgili adımları içeren rehberleri yazılı hale getiren ülkelerdendir. Bu rehberlerde bulaş açısından riskli invaziv girişimlerin tanımları yapılmış, enfekte çalışanın bu girişimleri yapabilmesi için sağlanması gereken kriterler belirlenmiştir. Yapılan çalışmalar ülkemizde mesleki yaralanma bildirimindeki yetersizlikleri ortaya koymaktadır. Bununla birlikte her üç etkenin klinik olarak sessiz seyredebiliyor olması ve sağlık personelinde düzenli serolojik taramalar için yasal bir zorunluluk olmayışı ülkemizde de sağlık çalışanından hastalara bulaşma ihtimalinin dikkate alınması gereken bir konu olduğunu düşündürmektedir. Biz bu derlemede sağlık çalışanından hastalara hepatit B, hepatit C ve HIV bulaşı ile ilgili uluslararası rehberleri ve ülkemiz verilerini inceleyerek, konuyu tıbbi, etik ve hukuki boyutuyla ele alırken çalışanın hak ve mahremiyetini de gözeten ulusal bir kılavuz oluşturulması gereksinimine dikkat çekmek istedik. İlgili meslek örgütlerimizin ortak görüşünü içeren bir rehberin hazırlanması gerek sağlık çalışanlarının gerekse hastaların riskini azaltarak Türkiye’de sağlık hizmetinin kalitesini de arttıracaktır.

  • A New Insight Into the Treatment-Naive HIV Infected Patients: Whole Blood Viscosity

    by Hakan Evren, Emine Ünal Evren, Elif Çekirdekçi, Kaya Süer, Figen Sarıgül Yıldırım, Ali Asan, Barış Buğan

  • Open Access

    Awareness and Knowledge of COVID-19 Among Health Care Workers in Early Phase of COVID-19 Pandemic

    by Serap Argun Barış, Emine Ünal Evren, Hakan Evren, Ece Şahinoğlu, Gözde Selvi, Haşim Boyacı, İlknur Başyiğit, Füsun Yıldız

    Awareness,COVID-19,healthcare workers,knowledge